Sanofi Demonstrates Commitment to Innovative Diabetes Care at International Diabetes Technology Conference (1)

PARIS, February 25, 2013 /PRNewswire/ --

- Data presented at ATTD by Sanofi will focus on the company's integrated

portfolio of therapeutic solutions, blood glucose monitoring, insulin delivery and

contributions to advancing diabetes research -

Sanofi announced today that its comprehensive portfolio of innovative diabetes solutions will be presented at the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Paris, France (February 27 - March 2). The annual ATTD conference is the leading diabetes technology meeting in Europe, and Sanofi will showcase its commitment to advancing therapeutic solutions and diabetes care technology aimed at improving patient outcomes.

Abstracts include the latest clinical data on the early benefits of Lantus(R) (insulin glargine), the accuracy, reliability and ease-of-use of the BGStar(R) and iBGStar(R) blood glucose meters, and the SoloSTAR(R) insulin delivery device. The study design of the biggest multi-national register of diabetes research in the young, TEENS, will also be featured.

In addition, Sanofi will sponsor a plenary satellite symposium at ATTD titled "Technology: Contributing to Diabetes Management Today and Tomorrow" which will provide an overview of current and future treatments, tools and projects to facilitate clinical decision making and empower patients to take control of their diabetes. The session will conclude with a presentation on the artificial pancreas in children.

"Today, effective diabetes management is increasingly a matter of simplifying day-to-day routines for people living with the condition. This means we need comprehensive approaches to diabetes care based on technological advances," said Pierre Chancel, Senior Vice President, Sanofi, Global Diabetes. "Sanofi's diabetes teams are dedicated to providing innovative and integrated technological solutions combined with patient support services that help people with diabetes effectively manage their disease while living the lives they want to live."

Highlights of the data being presented are as follows (abstracts are available on the ATTD website http://www2.kenes.com/attd ):

        
        iNewTrend study: "Effect of Glucose Monitoring with Smartphone Integration on Metabolic
         Control and Compliance in Type 1 Diabetes (iNew Trend): Study Design"
        When:        Session 26: Oral Presentations, Saturday 2 March, 12:20 - 12:30pm CET
        Presenter:   V. Cherubini, Polytechnic University of Marche, Ancona, Italy
        Where:       CNIT Paris La Defense Exhibition Hall, Hall III
        EARLY LANTUS study: "Early Onset of Glycaemic Improvements after Insulin Initiation
         with Insulin Glargine in Patients with Type 2 Diabetes Mellitus Uncontrolled with
         OADs: Pooled Analysis from Clinical Trials"
        When:        Poster Session 2, Friday 1 March, 8:00am - 17:00pm CET
        Presenter:   D.R. Owens, Institute of Molecular and Experimental Medicine, Cardiff, UK
        Where:       CNIT Paris La Defense Exhibition Hall, Poster Area
        LANTUS survey: "Survey on Physician Experiences in Initiation of Insulin in Type 2
         Diabetes Patients: Preliminary Results for Insulin Glargine"
        When:        Poster Session 2, Friday 1 March, 8:00am - 17:00pm CET
        Presenter:   R. Roussel, Diabetology, Endocrinology and Nutrition Department, Paris,
         France
        Where:       CNIT Paris La Defense Exhibition Hall, Poster Area
        TEENS study: "International Evaluation of Diabetes Management, Glycaemic Control and
         Quality of Life in Youth with Type 1 Diabetes: the TEENS Study"
        When:        E-Poster Session 4, Friday 1 March, 10:00am CET
        Presenter:   L. Laffel, Harvard Medical School, Boston, USA
        Where:       CNIT Paris La Defense Exhibition Hall, Exhibition Area, Poster Station 2
        BGStar(R) and iBGStar(R) abstracts include:
        "Assessment of Ascorbic Acid and Acetaminophen Interference on the Performance of Blood
         Glucose Meters for Patient Self-Testing"
        When:        Poster Session, Thursday 28 February, 8:00am - 17:00pm CET
        Presenter:   A. Pfützner, IKFE - Institute for Clinical Research and Development,
         Mainz, Germany
        Where:       CNIT Paris La Defense Exhibition Hall, Poster Area
        "Laboratory Study for Evaluation of the Influence of Temperature and Humidity on Blood
         Glucose Measurements with BGStar and iBGStar"
        When:        Poster Session, Thursday 28 February, 8:00am - 17:00pm CET
        Presenter:   A. Pfützner, IKFE - Institute for Clinical Research and Development,
         Mainz, Germany
        Where:       CNIT Paris La Defense Exhibition Hall, Poster Area
        "Performance of Current Blood Glucose Meters in Compliance with the New Draft Clinical
         ISO15197: 2010 Accuracy Criteria"
        When:        Poster Session, Thursday 28 February, 8:00am - 17:00pm CET
        Presenter:   A. Pfützner, IKFE - Institute for Clinical Research and Development,
         Mainz,
         Germany
        Where:       CNIT Paris La Defense Exhibition Hall, Poster Area
        "Impact of Strip Filling on the Performance of Glucose Meters for Patient Self-Testing"
        When:        Poster Session, Thursday 28 February, 8:00am - 17:00pm CET
        Presenter:   A. Pfützner, IKFE - Institute for Clinical Research and Development,
         Mainz, Germany
        Where:       CNIT Paris La Defense Exhibition Hall, Poster Area
        SoloSTAR(R) abstracts include:
        "Field Study on Rotational Speeds and Angles used by Patients Dialing a Dose on Four
         Different Disposable Insulin Pens"
        When:        E-Poster Session 1, Thursday 28 February, 10:05am CET
        Presenter:   A. Friedrichs, LWS Risk Management Consult GmbH, Brannenburg, Germany
        Where:       CNIT Paris La Defense Exhibition Hall, Exhibition Area, Poster Station 1
        "Torque for Dose Dialing of Four Disposable Insulin Pens SoloSTAR, FlexTouch, FlexPen,
         and KwikPen: Results of a Laboratory Study"
        When:        Poster Session 2, Friday 1 March, 8:00am - 17:00pm CET
        Presenter:   A. Friedrichs, LWS Risk Management Consult GmbH, Brannenburg, Germany
        Where:       CNIT Paris La Defense Exhibition Hall, Poster Area
        Sanofi-Sponsored Plenary Satellite Symposium:
        "Technology: Contributing to Diabetes Management Today and Tomorrow"
        When:        Session 8: Plenary Satellite Symposium, Thursday 28 February, 15:00 -
         16:30pm CET
        Chairman:    L. Heinemann, Profil Institute for Metabolic Research, Neuss, Germany
        Where:       CNIT Paris La Defense Exhibition Hall, Hall I

About Diabetes

(CONTINUA)